JANONE INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.1 USD | -4.65% |
|
+4.83% | +642.34% |
| Apr. 18 | JanOne Files Prospectus for $100 Million Mixed Shelf Offering | MT |
| Apr. 15 | North American Morning Briefing : Stock Futures -2- | DJ |
Presentation Operator MessageOperator (Operator)Welcome to the Appliance Recycling Centers of ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
JanOne Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, licensing, developing, partnering, and commercializing novel, no-opioid, and non-addictive therapies to address the large, unmet medical need for the treatment of pain and addiction. Its drug candidate, JAN101, is a patented oral, sustained-release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities, such as those with vascular complications of diabetes or Peripheral Artery Disease (PAD) and treats pain. The Companyâs drug candidate is a treatment for Peripheral Artery Disease, a condition that can cause severe pain and affects over 8.5 million people in the United States. The Company operates through the Biotechnology segment, which is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.
| 1st Jan change | Capi. | |
|---|---|---|
| +642.34% | 37.3M | |
| +24.44% | 46.71B | |
| +48.83% | 41.8B | |
| -0.94% | 41.52B | |
| -5.86% | 29.55B | |
| +10.99% | 25.78B | |
| -21.06% | 19.26B | |
| +3.12% | 12.14B | |
| -2.17% | 12.08B | |
| +30.08% | 11.98B |
- Stock Market
- Equities
- JAN Stock
- News JanOne Inc.
- Transcript : Appliance Recycling Centers of America Inc., Q1 2012 Earnings Call, May 08, 2012